Airway clearance techniques (ACTs) are part of the main management strategy for patients
with bronchiectasis. Despite being a priority for patients, accessibility, implementation and …

CT scanning can also aid in identifying an aetiology of bronchiectasis eg Allergic
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary …

Introduction Throughout the years, a decreasing trend in mortality rate has been
demonstrated in patients suffering severe trauma. This increases the relevance of …

Background Bronchiectasis guidelines recommend long-term macrolide treatment for
patients with three or more exacerbations per year without Pseudomonas aeruginosa …

Health-related quality of life or health status is significantly impaired in bronchiectasis. There
is a paucity of brief, simple-to-use, disease-specific health status measures. The aim of this …

Background Tiotropium via the HandiHaler device is an established long-acting,
anticholinergic bronchodilator that prevents exacerbations and improves lung function in …

Background and objective Inspiratory muscle training (IMT) enhances velocity of inspiratory
muscle contraction and modifies inspiratory and expiratory time. This study aimed to …

Background Using treatable traits as a management approach in bronchiectasis involves
determining identifiable, clinically relevant, measurable and treatable problems to develop a …

Background The long-term outcomes of COVID-19 hospitalisation in individuals with pre-
existing airway diseases are unknown. Methods Adult participants hospitalised for confirmed …

Bronchiectasis, a once-neglected disease, has gained increased recognition in the past
decade. The reported prevalence of bronchiectasis is increasing, reaching 0.25% to 0.5% of …